News Column

New Liposomes Findings from Peking University Discussed (Recent advances in liposomal nanohybrid cerasomes as promising drug nanocarriers)

July 24, 2014



By a News Reporter-Staff News Editor at Gene Therapy Weekly -- Investigators publish new report on Biotechnology. According to news reporting from Beijing, People's Republic of China, by NewsRx journalists, research stated, "Liposomes have been extensively investigated as possible carriers for diagnostic or therapeutic agents due to their unique properties. However, liposomes still have not attained their full potential as drug and gene delivery vehicles because of their insufficient morphological stability."

The news correspondents obtained a quote from the research from Peking University, "Recently, a super-stable and freestanding hybrid liposomal cerasome (partially ceramic- or silica-coated liposome) has drawn much attention as a novel drug delivery system because its atomic layer of polyorganosiloxane surface imparts higher morphological stability than conventional liposomes and its liposomal bilayer structure reduces the overall rigidity and density greatly compared to silica nanoparticles. Cerasomes are more biocompatible than silica nanoparticles due to the incorporation of the liposomal architecture into cerasomes. Cerasomes combine the advantages of both liposomes and silica nanoparticles but overcome their disadvantages so cerasomes are ideal drug delivery systems."

According to the news reporters, the research concluded: "The present review will first highlights some of the key advances of the past decade in the technology of cerasome production and then review current biomedical applications of cerasomes, with a view to stimulating further research in this area of study."

For more information on this research see: Recent advances in liposomal nanohybrid cerasomes as promising drug nanocarriers. Advances in Colloid and Interface Science, 2014;207():32-42. Advances in Colloid and Interface Science can be contacted at: Elsevier Science Bv, PO Box 211, 1000 Ae Amsterdam, Netherlands. (Elsevier - www.elsevier.com; Advances in Colloid and Interface Science - www.elsevier.com/wps/product/cws_home/500842)

Our news journalists report that additional information may be obtained by contacting X.L. Yue, Peking University, Coll Engn, Dept. of Biomed Engn, Beijing 100871, People's Republic of China (see also Biotechnology).

Keywords for this news article include: Asia, Biotechnology, Beijing, Therapy, Liposomes, Nanocarriers, Nanoparticle, Nanotechnology, Drug Delivery Systems, Emerging Technologies, People's Republic of China

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Gene Therapy Weekly


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters